Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan Qin

Showing results (221-230 of 236) with videos related to

Pageof 24
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 3, 2021
Prognostic index for estimating the survival benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: A real-world validation studyChen-Chen Zhang, Run-Ping Hou, Wu-Yan Xia, et al.
Aging|April 22, 2021
Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphomaWen-Xing Li, Shao-Xing Dai, San-Qi An, et al.
BMC Cancer|November 18, 2020
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumoursYvonne L E Ang, Gwo Fuang Ho, Ross A Soo, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidinesJoline S J Lim, Samuel G W Ow, Andrea L A Wong, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 12, 2023
Health-related quality of life in Chinese SLE patients: evidence from 1568 SLE patients and 2610 healthy controlsYu-Hua Wang, Hong-Yu Sun, Yu-Qi Liu, et al.
Breast Cancer Research and Treatment|December 20, 2021
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancerKritika Yadav, Joline Lim, Joan Choo, et al.
Cancer Medicine|February 3, 2026
Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122Anthony T C Chan, Victor Ho Fun Lee, Ruey-Long Hong, et al.
Lupus|October 4, 2022
Associations of RPEL1 and miR-1307 gene polymorphisms with disease susceptibility, glucocorticoid efficacy, anxiety, depression, and health-related quality of life in Chinese systemic lupus erythematosus patientsZi-Ye Yan, Wan-Qin Hu, Qi-Qun Zong, et al.
Immunologic Research|September 14, 2022
An association study on the risk, glucocorticoids effectiveness, and prognosis of systemic lupus erythematosus: insight from mitochondrial DNA copy numberZhen Li, Qi-Qun Zong, Chun-Xia Zhai, et al.
Targeted Oncology|June 14, 2022
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis InhibitorsJoan R E Choo, Yi-Hua Jan, Samuel G W Ow, et al.
Pageof 24

Showing results (221-230 of 236) with videos related to

Sort By:
Pageof 24
Lung Cancer (Amsterdam, Netherlands)|May 3, 2021
Prognostic index for estimating the survival benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: A real-world validation studyChen-Chen Zhang, Run-Ping Hou, Wu-Yan Xia, et al.
Aging|April 22, 2021
Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphomaWen-Xing Li, Shao-Xing Dai, San-Qi An, et al.
BMC Cancer|November 18, 2020
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumoursYvonne L E Ang, Gwo Fuang Ho, Ross A Soo, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidinesJoline S J Lim, Samuel G W Ow, Andrea L A Wong, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 12, 2023
Health-related quality of life in Chinese SLE patients: evidence from 1568 SLE patients and 2610 healthy controlsYu-Hua Wang, Hong-Yu Sun, Yu-Qi Liu, et al.
Breast Cancer Research and Treatment|December 20, 2021
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancerKritika Yadav, Joline Lim, Joan Choo, et al.
Cancer Medicine|February 3, 2026
Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122Anthony T C Chan, Victor Ho Fun Lee, Ruey-Long Hong, et al.
Lupus|October 4, 2022
Associations of RPEL1 and miR-1307 gene polymorphisms with disease susceptibility, glucocorticoid efficacy, anxiety, depression, and health-related quality of life in Chinese systemic lupus erythematosus patientsZi-Ye Yan, Wan-Qin Hu, Qi-Qun Zong, et al.
Immunologic Research|September 14, 2022
An association study on the risk, glucocorticoids effectiveness, and prognosis of systemic lupus erythematosus: insight from mitochondrial DNA copy numberZhen Li, Qi-Qun Zong, Chun-Xia Zhai, et al.
Targeted Oncology|June 14, 2022
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis InhibitorsJoan R E Choo, Yi-Hua Jan, Samuel G W Ow, et al.
Pageof 24